Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong · Delayed Price · Currency is HKD 16.38
+0.49 (3.08%)
Jun 18, 2026, 4:08 PM HKT
HKG:1877 Market Cap
HKG:1877 has a market cap or net worth of 30.97 billion as of June 18, 2026. Its market cap has increased by 4.85% in one year.
Market Cap
30.97B
Enterprise Value
32.80B
Revenue
3.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
16.38
Market Cap Chart
Since December 24, 2018, HKG:1877's market cap has increased from 18.06B to 30.97B, an increase of 71.52%. That is a compound annual growth rate of 7.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 30.97B | -10.63% |
| Dec 31, 2025 | 34.66B | 39.72% |
| Dec 31, 2024 | 24.81B | -37.28% |
| Dec 29, 2023 | 39.55B | -38.85% |
| Dec 30, 2022 | 64.67B | -7.04% |
| Dec 31, 2021 | 69.57B | -9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 58.19B |
| 3SBio | 41.21B |
| Biocytogen Pharmaceuticals (Beijing) | 39.27B |
| Shanghai Henlius Biotech | 32.53B |
| Genscript Biotech | 25.12B |
| InnoCare Pharma | 22.31B |
| Metis TechBio | 16.60B |
| Keymed Biosciences | 16.59B |